An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Crescita Therapeutics Inc. (TSX: CTX, OTC US: CRRTF) announced CEO Serge Verreault will present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 3, 2022, at 10:30 a.m. in Hall A at the Metro Toronto Convention Centre. The conference, occurring on May 2-3, features around 60 leading healthcare companies from Canada. Verreault will outline Crescita’s recent business highlights and growth strategy, with the management team available for one-on-one investor meetings. For more details, visit bloomburton.com/conference.
Positive
None.
Negative
None.
LAVAL, Quebec--(BUSINESS WIRE)--
Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”) today announced that its CEO, Serge Verreault, will be presenting at the 2022 Bloom Burton & Co.Healthcare Investor Conference, to be held on May 2 and 3, 2022, featuring approximately 60 of Canada's most promising publicly-traded and venture-backed healthcare companies.
This year's event will be held in person and will provide investors the opportunity to hear about the latest developments in the Canadian healthcare industry. Details are as follows:
Location:Metro Toronto Convention Centre (North Building)
30-minute Presentation by Crescita:May 3 @ 10:30 a.m., Hall A
Mr. Verreault will discuss recent business highlights and the Company’s growth strategy. Members of Crescita’s management team will also be available for 1-on-1 investor meetings. For information or registration, visit bloomburton.com/conference.
About Crescita Therapeutics Inc.
Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. The Company offers a portfolio of high-quality, science-based non-prescription skincare products and early to commercial stage prescription products. We also own multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. For more information, please visit www.crescitatherapeutics.com.
About Bloom Burton & Co.
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).
About the Conference
The Bloom Burton & Co.Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.
